BUY MBP OVUDINE 300 MG/LAMIVUDINE 150 MG/NEVIRAPINE 200 LAZID N 60Tab BEST PRICE ONLINE IN NIGERIA LAGOS ABUJA KANO AND PORTHARCOURT AT MYBIGPHARMACY.COM

Description

Dear friend, this medication requires a prescription or medical license before it can be delivered to you. kindly ensure that you provide us with a reliable contact information at checkout, mybigpharmacy team will be in touch with you to obtain required document before your order is confirmed thank you for trusting mybig pharmacy with your health. Ovudine 300 mg / Lamivudine 150 mg / Nevirapine 200 mg, commonly known by the brand name Lazid-N, is a fixed-dose combination antiretroviral medicine used for the treatment of HIV infection. It helps control the virus, strengthen the immune system, and prevent progression to AIDS when taken correctly and consistently.

This combination contains three medicines that work together to stop HIV from multiplying. Zidovudine (also called AZT) and lamivudine are nucleoside reverse transcriptase inhibitors. They work by blocking an enzyme called reverse transcriptase, which HIV needs to make copies of itself. Nevirapine is a non-nucleoside reverse transcriptase inhibitor that blocks the same enzyme but in a different way. Together, these medicines reduce the amount of virus in the blood and help protect the immune system.

Ovudine is usually taken twice daily, approximately 12 hours apart, with or without food. It is very important to take the medicine at the same time every day. Missing doses can allow the virus to multiply and develop resistance, making treatment less effective or ineffective.

During the first few weeks of treatment, some people may experience side effects as the body adjusts. Common side effects include nausea, vomiting, tiredness, headache, dizziness, abdominal discomfort, and mild diarrhoea. These symptoms often improve after the first few weeks of therapy.

Nevirapine can cause skin rashes, which may range from mild to severe. A mild rash may resolve on its own, but if the rash is severe, painful, blistering, involves the mouth or eyes, or is associated with fever, the medicine must be stopped immediately and medical attention sought. The risk of rash is highest within the first 6 weeks of treatment.

Nevirapine can also affect the liver. Signs of liver problems include yellowing of the eyes or skin, dark urine, pale stools, nausea, vomiting, abdominal pain, or severe fatigue. Liver function tests are usually monitored regularly, especially during the first few months of treatment. People with hepatitis B or C require close monitoring.

Zidovudine can affect the bone marrow, leading to low red blood cells or white blood cells. This may cause tiredness, weakness, shortness of breath, or increased risk of infections. Regular blood tests are important to monitor blood counts.

Lamivudine is generally well tolerated, but stopping it suddenly in people with hepatitis B can cause a flare-up of liver disease. For this reason, treatment should never be stopped without medical advice.

Ovudine should be used with caution during pregnancy and only under medical supervision. Nevirapine carries a higher risk of liver toxicity in women with higher CD4 counts. Breastfeeding is not recommended for people living with HIV due to the risk of transmission.

Certain medicines can interact with Ovudine, including some antibiotics, antifungals, tuberculosis medicines, and herbal supplements such as St John?s wort. Alcohol should be limited, as it may increase the risk of liver damage.

When taken consistently and correctly, Ovudine helps suppress HIV to very low or undetectable levels, improves immune function, reduces the risk of opportunistic infections, and helps people living with HIV live longer and healthier lives. Adherence to treatment, regular medical follow-up, and open communication with healthcare providers are essential for successful long-term management.